The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Protein aggregation and its impact on product quality
Open accessAbstract
Protein pharmaceutical products are typically active as folded monomers that are composed of one or more protein chains, such as the heavy and light chains in monoclonal antibodies that are a mainstay of current drug pipelines. There are numerous possible aggregated states for a given protein, some of which are potentially useful, while most of which are considered deleterious from the perspective of pharmaceutical product quality and performance. This review provides an overview of how and why different aggregated states of proteins occur, how this potentially impacts product quality and performance, fundamental approaches to control aggregate formation, and the practical approaches that are currently used in the pharmaceutical industry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creighton, T. E. (1992) · Cited by 1,583
Protein aggregation: folding aggregates, inclusion bodies and amyloid
Fink, A. L. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00002-9 · Cited by 1,157
Principles of protein–protein recognition
Chothia, C., & Janin, J. (1975) · Nature · doi:10.1038/256705a0 · Cited by 1,039
Protein aggregation and its inhibition in biopharmaceutics
Wang, W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.014 · Cited by 983
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 520
Toward Understanding Insulin Fibrillation
Brange, J., Andersen, L., Laursen, E. D., Meyn, G., & Rasmussen, E. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960297s · Cited by 510
Introduction to protein crystallization
McPherson, A., & Gavira, J. A. (2014) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x13033141 · Cited by 491
Therapeutic protein aggregation: mechanisms, design, and control
Roberts, C. J. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.05.005 · Cited by 455
Self-citationCavities determine the pressure unfolding of proteins
Roche, J., Caro, J. A., Norberto, D. R., Barthe, P., Roumestand, C., Schlessman, J. L., Garcia, A. E., García-Moreno E., B., & Royer, C. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200915109 · Cited by 385
Connolly, B. D., Petry, C., Yadav, S., Demeule, B., Ciaccio, N., Moore, J. M. R., Shire, S. J., & Gokarn, Y. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.047 · Cited by 340
Non‐native protein aggregation kinetics
Roberts, C. J. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21627 · Cited by 329
Self-citationPrinciples, approaches, and challenges for predicting protein aggregation rates and shelf life
Weiss, W. F., Young, T. M., & Roberts, C. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21521 · Cited by 308
Self-citationStructure and Stability Changes of Human IgG1 Fc as a Consequence of Methionine Oxidation
Liu, D., Ren, D., Huang, H., Dankberg, J., Rosenfeld, R., Cocco, M. J., Li, L., Brems, D. N., & Remmele, R. L. (2008) · Biochemistry · doi:10.1021/bi702238b · Cited by 261
Auton, M., Rösgen, J., Sinev, M., Holthauzen, L. M. F., & Bolen, D. W. (2011) · Biophysical Chemistry · doi:10.1016/j.bpc.2011.05.012 · Cited by 258
Wakankar, A. A., & Borchardt, R. T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20740 · Cited by 254
What's fueling the biotech engine—2012 to 2013
(Rob) Aggarwal, S. (2014) · Nature Biotechnology · doi:10.1038/nbt.2794 · Cited by 254
Jiskoot, W., Randolph, T. W., Volkin, D. B., Russell Middaugh, C., Schöneich, C., Winter, G., Friess, W., Crommelin, D. J. A., & Carpenter, J. F. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23018 · Cited by 251
Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences
Torosantucci, R., Schöneich, C., & Jiskoot, W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1199-9 · Cited by 215
Dumetz, A. C., Snellinger‐O'Brien, A. M., Kaler, E. W., & Lenhoff, A. M. (2007) · Protein Science · doi:10.1110/ps.072957907 · Cited by 203
Understanding and Modulating Opalescence and Viscosity in a Monoclonal Antibody Formulation
Salinas, B. A., Sathish, H. A., Bishop, S. M., Harn, N., Carpenter, J. F., & Randolph, T. W. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21797 · Cited by 191
Non-Arrhenius Protein Aggregation
Wang, W., & Roberts, C. J. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9485-3 · Cited by 158
Self-citationEvaluation of Hofmeister Effects on the Kinetic Stability of Proteins
Broering, J. M., & Bommarius, A. S. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp053618+ · Cited by 157
Oral peptide and protein delivery: intestinal obstacles and commercial prospects
Smart, A. L., Gaisford, S., & Basit, A. W. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.917077 · Cited by 143
Predicting solution aggregation rates for therapeutic proteins: Approaches and challenges
Roberts, C. J., Das, T. K., & Şahin, E. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.064 · Cited by 141
Self-citationBee, J. S., Schwartz, D. K., Trabelsi, S., Freund, E., Stevenson, J. L., Carpenter, J. F., & Randolph, T. W. (2012) · Soft Matter · doi:10.1039/c2sm26184g · Cited by 128
Yearley, E. J., Zarraga, I. E., Shire, S. J., Scherer, T., Gokarn, Y. R., Wagner, N. J., & Liu, Y. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.06.043 · Cited by 125
Protein interactions and association: an open challenge for colloid science
Piazza, R. (2004) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2004.01.008 · Cited by 124
Evaluation of a Non-Arrhenius Model for Therapeutic Monoclonal Antibody Aggregation
Kayser, V., Chennamsetty, N., Voynov, V., Helk, B., Forrer, K., & Trout, B. L. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22493 · Cited by 120
Insulin formulations--a review.
Gualandi-Signorini, A. M., & Giorgi, G. (2001) · PubMed · Cited by 120
Aggregation of a monoclonal antibody induced by adsorption to stainless steel
Bee, J. S., Davis, M., Freund, E., Carpenter, J. F., & Randolph, T. W. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22525 · Cited by 113
Sukumar, M., Doyle, B. L., Combs, J. L., & Pekar, A. H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032993.98705.73 · Cited by 108
Li, Y., Ogunnaike, B. A., & Roberts, C. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21869 · Cited by 103
Self-citationBrummitt, R. K., Nesta, D. P., Chang, L., Kroetsch, A. M., & Roberts, C. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22447 · Cited by 93
Self-citationMason, B. D., Enk, J. Z.-V., Zhang, L., Remmele, R. L., & Zhang, J. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.10.040 · Cited by 92
Hydrostatic pressure rescues native protein from aggregates
Foguel, D., Robinson, C. R., de Sousa, P. C., Silva, J. L., & Robinson, A. S. (1999) · Biotechnology and Bioengineering · Cited by 92
Kim, N., Remmele, R. L., Liu, D., Razinkov, V. I., Fernández, E., & Roberts, C. J. (2012) · Biophysical Chemistry · doi:10.1016/j.bpc.2012.12.004 · Cited by 89
Self-citationAntibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks
Macdougall, I. C. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1087 · Cited by 81
Wiesbauer, J., Prassl, R., & Nidetzky, B. (2013) · Langmuir · doi:10.1021/la4028223 · Cited by 80
Intermediate range order and structure in colloidal dispersions with competing interactions
Godfrin, P. D., Castañeda-Priego, R., Liu, Y., & Wagner, N. J. (2013) · The Journal of Chemical Physics · doi:10.1063/1.4824487 · Cited by 78
Interactions and phase behavior of a monoclonal antibody
Lewus, R. A., Darcy, P. A., Lenhoff, A. M., & Sandler, S. I. (2010) · Biotechnology Progress · doi:10.1002/btpr.536 · Cited by 75
Smejkal, B. M., Agrawal, N. J., Helk, B., Schulz, H., Giffard, M., Mechelke, M., Ortner, F., Heckmeier, P. J., Trout, B. L., & Hekmat, D. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24908 · Cited by 73
Banks, D. D., Latypov, R. F., Ketchem, R. R., Woodard, J., Scavezze, J. L., Siska, C. C., & Razinkov, V. I. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23219 · Cited by 69
Fernández, C., & Minton, A. P. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.11.054 · Cited by 68
Nonnative Protein Polymers: Structure, Morphology, and Relation to Nucleation and Growth
Weiss, W. F., Hodgdon, T. K., Kaler, E. W., Lenhoff, A. M., & Roberts, C. J. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.112102 · Cited by 67
Self-citationDo Clustering Monoclonal Antibody Solutions Really Have a Concentration Dependence of Viscosity?
Pathak, J. A., Sologuren, R. R., & Narwal, R. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.01.007 · Cited by 64
Aggregation and pH–Temperature Phase Behavior for Aggregates of an IgG2 Antibody
Şahin, E., Weiss, W. F., Kroetsch, A. M., King, K. R., Kessler, R. K., Das, T. K., & Roberts, C. J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23056 · Cited by 64
Self-citationHigh‐pressure refolding of bikunin: Efficacy and thermodynamics
Seefeldt, M. B., Ouyang, J., Froland, W. A., Carpenter, J. F., & Randolph, T. W. (2004) · Protein Science · doi:10.1110/ps.04891204 · Cited by 48
Orally active-targeted drug delivery systems for proteins and peptides
Li, X., Yu, M., Fan, W., Gan, Y., Hovgaard, L., & Yang, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.924500 · Cited by 44
Mahler, H., Fischer, S., Randolph, T. W., & Carpenter, J. F. (2010) · Wiley eBooks · doi:10.1002/9780470769829.ch7 · Cited by 35
Effects of Temperature and Osmolytes on Competing Degradation Routes for an IgG1 Antibody
Roberts, C. J., Nesta, D. P., & Kim, N. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23668 · Cited by 32
Self-citationSaluja, A., Sadineni, V., Mungikar, A. A., Nashine, V. C., Kroetsch, A. M., Dahlheim, C., & Rao, V. M. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1263-5 · Cited by 28
Effects of additives on surfactant phase behavior relevant to bacteriorhodopsin crystallization
Berger, B. W., Gendron, C. M., Lenhoff, A. M., & Kaler, E. W. (2006) · Protein Science · doi:10.1110/ps.062370506 · Cited by 25
Lin, H.-K., Chase, S. F., Laue, T. M., Jen‐Jacobson, L., & Trakselis, M. A. (2012) · Biochemistry · doi:10.1021/bi300956t · Cited by 21
Kroetsch, A. M., Şahin, E., Wang, H., Krizman, S., & Roberts, C. J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23264 · Cited by 19
Self-citation
Cited by
Protein aggregation – Mechanisms, detection, and control
Wang, W., & Roberts, C. J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.043 · Cited by 299
Self-citationAlphaFold and the amyloid landscape
Pinheiro, F., Santos, J., & Ventura, S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167059 · Cited by 88
Graf, T., Heinrich, K., Grunert, I., Wegele, H., Haberger, M., Bulau, P., & Leiss, M. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113251 · Cited by 46
A3D 2.0 update for the prediction and optimization of protein solubility
Pujols, J., Iglesias, V., Santos, J., Kuriata, A., Kmiecik, S., & Ventura, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1859-2_3 · Cited by 19
Metadata
- Authors
- Roberts, C. J.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 30
- Pages
- 211-217
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W2030185855
- Cited by
- 316
- References
- 54
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.